I. Hahntow

发表

Expression of cyclin E in resting and activated B‐chronic lymphocytic leukaemia cells: cyclin E/cdk2 as a potential therapeutic target

C. Peschel, T. Decker, S. Hipp, 2004, British journal of haematology.

Cyclin-dependent kinase inhibitor Roscovitine induces apoptosis in chronic lymphocytic leukemia cells

C. Peschel, T. Decker, I. Hahntow, 2004, Leukemia.

Impact of GPCRs in clinical medicine: monogenic diseases, genetic variants and drug targets.

P. Insel, I. Hahntow, M. Michel, 2007, Biochimica et biophysica acta.

The beta2-adrenoceptor gene and hypertension: is it the promoter or the coding region or neither?

I. Hahntow, R. Koopmans, M. C. Michel, 2006, Journal of hypertension.

Are "functionally related polymorphisms" of renin-angiotensin-aldosterone system gene polymorphisms associated with hypertension?

I. Hahntow, I. V. van Valkengoed, R. Koopmans, 2010, BMC cardiovascular disorders.

Impact of chronic kidney disease on carotid plaque vulnerability.

I. Hahntow, P. Luppa, J. Pelisek, 2011, Journal of vascular surgery.

The angiotensin converting enzyme insertion/deletion polymorphism and differences in fasting plasma glucose in Hindustani Surinamese, African Surinamese and ethnic Dutch: the population-based SUNSET-study.

K. Stronks, I. Hahntow, F. Holleman, 2008, Diabetes research and clinical practice.

Are RGS2 gene polymorphisms associated with high blood pressure in an ethnicity- and gender-specific manner?

F. Baas, I. Hahntow, I. V. van Valkengoed, 2009, American journal of hypertension.

Multiple gene approaches to delineate the role of the renin-angiotensin-aldosterone system in nephropathy.

I. Hahntow, R. Koopmans, M. C. Michel, 2005, Journal of hypertension.